27.9 C
New York
Wednesday, June 10, 2026

Tag: signatures

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...

Argenta Silver Drills 533 g/t Silver over 20.20 meters, including 3,549 g/t Silver over 1.00 meter from its Inaugural Drill Program at El Quevar

TSX-V: AGAG VANCOUVER, BC, July 21, 2025 /CNW/ - Argenta Silver Corp. (TSXV: AGAG) (OTCQB: AGAGF) (FSE: T1K) ("Argenta" or the "Company") is pleased to report...

U.S. GoldMining Announces 2025 Exploration Program Targeting Continued Growth at the District Scale Whistler Gold-Copper Project, Alaska

ANCHORAGE, Alaska, July 21, 2025 /PRNewswire/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to provide an update on the...

ARGAN : S1 2025 – Forte croissance et objectifs 2025 confirmés

Résultats semestriels – Neuilly-sur-Seine, jeudi 17 juillet 2025 - 17h45

Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology  and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger.

ETRUSCUS LAUNCHES INAUGURAL DRILL PROGRAM AT ZAPPA PORPHYRY TARGET IN GOLDEN TRIANGLE

VANCOUVER, BC, July 10, 2025 /CNW/ - Etruscus Resources Corp. (CSE: ETR) (OTC: ETRUF) (FSE:ERR) (the "Company" or "Etruscus") is pleased to announce the commencement...

Therap Enhances Secure Document Signing with Added ‘Order’ Module Search Option in Reference Module Dropdown

TORRINGTON, Conn., July 8, 2025 /PRNewswire/ -- Therap Services, the leading provider of HIPAA-compliant electronic documentation solutions for organizations and agencies in Long-Term Services and...

ARGAN et REXEL unissent leurs forces : les émissions CO2 du site de Cestas divisées par 14

Communiqué de presse – Neuilly-sur-Seine, mardi 8 juillet 2025 – 17h45

Mercy BioAnalytics Appoints Dr. Prasanth Reddy as Chief Medical Officer

WALTHAM, Mass., July 8, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today...

Investor Faces Backlash for Daring to Think—How Scandalous!

In a delightful twist of modern absurdity, Shaun Maguire of Sequoia Capital decided to channel his inner provocateur by labeling Zohran Mamdani, a Democratic...

mRNA Sequencing Market Size to Hit USD 4.02 billion by 2031, Growing at 13.6% CAGR, Benefits from Surging Prevalence of Cancer | The Insight...

NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA sequencing market is observing...

CathVision Announces New Software Release and New Board Appointment

COPENHAGEN, Denmark, July 7, 2025 /PRNewswire/ -- CathVision ApS, a medical technology company developing electrophysiology solutions for cardiac ablation, announces the market release of...

- A word from our sponsors -

spot_img
HomeTagsSignatures